A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells

Similar Items

• M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
  od: Knudson, Karin M., i dr.
  Izdano: (2018)
• Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824)
  od: Jochems, Caroline, i dr.
  Izdano: (2017)
• Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
  od: Strauss, Julius, i dr.
  Izdano: (2018)
• Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer
  od: Dominguez, Charli, i dr.
  Izdano: (2017)
• Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
  od: Lind, Hanne, i dr.
  Izdano: (2020)